Bio/Pharma News

Apr 17, 2018
By Pharmaceutical Technology Editors
According to Alexion, the acquisition will help rebuild its clinical pipeline.
Apr 12, 2018
By Pharmaceutical Technology Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
Apr 11, 2018
By Pharmaceutical Technology Editors
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
Apr 09, 2018
By Pharmaceutical Technology Editors
Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.
Apr 09, 2018
By Pharmaceutical Technology Editors
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
Apr 09, 2018
By Pharmaceutical Technology Editors
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
Apr 09, 2018
By Pharmaceutical Technology Editors
The acquisition is expected to accelerate progress towards personalized cancer healthcare.
Apr 06, 2018
By Pharmaceutical Technology Editors
Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.
Apr 05, 2018
By Pharmaceutical Technology Editors
The European approval marks the first approval for a biosimilar in that region resulting from the companies’ joint portfolio.
Apr 05, 2018
By Pharmaceutical Technology Editors
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
native1_300x100
lorem ipsum